Cargando…

Association between hypertension and the prevalence of liver steatosis and fibrosis

BACKGROUND: Hypertension (HTN) and non-alcoholic fatty liver disease (NAFLD) frequently coexist and share pathophysiological symptoms. Based on the liver stiffness measurement and controlled attenuation parameter obtained by performing liver transient ultrasound elastography (TUE), we determined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Huanjie, Yu, Hao, Zhao, Yisheng, Chen, Jinhong, Liu, Zhichao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116756/
https://www.ncbi.nlm.nih.gov/pubmed/37081417
http://dx.doi.org/10.1186/s12902-023-01318-1
_version_ 1785028492619939840
author Fu, Huanjie
Yu, Hao
Zhao, Yisheng
Chen, Jinhong
Liu, Zhichao
author_facet Fu, Huanjie
Yu, Hao
Zhao, Yisheng
Chen, Jinhong
Liu, Zhichao
author_sort Fu, Huanjie
collection PubMed
description BACKGROUND: Hypertension (HTN) and non-alcoholic fatty liver disease (NAFLD) frequently coexist and share pathophysiological symptoms. Based on the liver stiffness measurement and controlled attenuation parameter obtained by performing liver transient ultrasound elastography (TUE), we determined the relationship between HTN status and the rates of liver steatosis and fibrosis in this study. METHODS: To perform this cross-sectional study, data were obtained from the National Health and Nutrition Examination Survey for 2017-March 2020 Pre-pandemic cycle. The relationship between HTN and the rates of liver steatosis and fibrosis was analyzed by constructing a multivariate logistic regression model. The VCTE was performed using a FibroScan® system (model 502, V2 Touch), and CAP was measured at ≥ 274 dB/m for liver steatosis, and the LSM result (median, ≥ 8 kPa) confirmed fibrosis. We also conducted subgroup analyses based on the age, sex, ethnicity, and body mass index (BMI) of the patients. RESULTS: In total, 4,705 participants were recruited, including 2,287 participants with HTN and 2,418 without HTN. After adjusting possible confounders, HTN was positively related to the liver steatosis rate (OR = 1.4, 95% CI: 1.1–1.8). Such HTN-associated prevalence was higher among males (OR = 1.6, 95% CI: 1.1–2.2), non-Hispanic African American individuals (OR = 2.1, 95% CI: 1.1–3.7), and participants with BMI ≥ 25 < 30 kg/m(2) (OR = 1.7, 95% CI: 1.1–2.5). Additionally, HTN was positively associated with the fibrosis rate (OR = 2.0, 95% CI: 1.3–3.0), especially among females (OR = 2.6, 95% CI: 1.3–5.2), among individuals who were 40–59 years old (OR = 2.1, 95% CI: 1.0–4.3), 60–80 years old (OR = 2.4, 95% CI:1.3–4.6), non-Hispanic Caucasian (OR = 2.9, 95% CI: 1.5–5.6), among those with BMI ≥ 25 < 30 kg/m(2) (OR = 3.0, 95% CI: 1.1–8.2), and those with BMI ≥ 30 kg/m(2) (OR = 2.1, 95% CI: 1.4–3.2). CONCLUSION: The results of this study revealed that HTN status was associated with higher rates of liver steatosis and fibrosis, particularly in subjects with BMI ≥ 25 kg/m(2). The ethnicity of the participants also had an impact on the relationship.
format Online
Article
Text
id pubmed-10116756
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101167562023-04-21 Association between hypertension and the prevalence of liver steatosis and fibrosis Fu, Huanjie Yu, Hao Zhao, Yisheng Chen, Jinhong Liu, Zhichao BMC Endocr Disord Research BACKGROUND: Hypertension (HTN) and non-alcoholic fatty liver disease (NAFLD) frequently coexist and share pathophysiological symptoms. Based on the liver stiffness measurement and controlled attenuation parameter obtained by performing liver transient ultrasound elastography (TUE), we determined the relationship between HTN status and the rates of liver steatosis and fibrosis in this study. METHODS: To perform this cross-sectional study, data were obtained from the National Health and Nutrition Examination Survey for 2017-March 2020 Pre-pandemic cycle. The relationship between HTN and the rates of liver steatosis and fibrosis was analyzed by constructing a multivariate logistic regression model. The VCTE was performed using a FibroScan® system (model 502, V2 Touch), and CAP was measured at ≥ 274 dB/m for liver steatosis, and the LSM result (median, ≥ 8 kPa) confirmed fibrosis. We also conducted subgroup analyses based on the age, sex, ethnicity, and body mass index (BMI) of the patients. RESULTS: In total, 4,705 participants were recruited, including 2,287 participants with HTN and 2,418 without HTN. After adjusting possible confounders, HTN was positively related to the liver steatosis rate (OR = 1.4, 95% CI: 1.1–1.8). Such HTN-associated prevalence was higher among males (OR = 1.6, 95% CI: 1.1–2.2), non-Hispanic African American individuals (OR = 2.1, 95% CI: 1.1–3.7), and participants with BMI ≥ 25 < 30 kg/m(2) (OR = 1.7, 95% CI: 1.1–2.5). Additionally, HTN was positively associated with the fibrosis rate (OR = 2.0, 95% CI: 1.3–3.0), especially among females (OR = 2.6, 95% CI: 1.3–5.2), among individuals who were 40–59 years old (OR = 2.1, 95% CI: 1.0–4.3), 60–80 years old (OR = 2.4, 95% CI:1.3–4.6), non-Hispanic Caucasian (OR = 2.9, 95% CI: 1.5–5.6), among those with BMI ≥ 25 < 30 kg/m(2) (OR = 3.0, 95% CI: 1.1–8.2), and those with BMI ≥ 30 kg/m(2) (OR = 2.1, 95% CI: 1.4–3.2). CONCLUSION: The results of this study revealed that HTN status was associated with higher rates of liver steatosis and fibrosis, particularly in subjects with BMI ≥ 25 kg/m(2). The ethnicity of the participants also had an impact on the relationship. BioMed Central 2023-04-20 /pmc/articles/PMC10116756/ /pubmed/37081417 http://dx.doi.org/10.1186/s12902-023-01318-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fu, Huanjie
Yu, Hao
Zhao, Yisheng
Chen, Jinhong
Liu, Zhichao
Association between hypertension and the prevalence of liver steatosis and fibrosis
title Association between hypertension and the prevalence of liver steatosis and fibrosis
title_full Association between hypertension and the prevalence of liver steatosis and fibrosis
title_fullStr Association between hypertension and the prevalence of liver steatosis and fibrosis
title_full_unstemmed Association between hypertension and the prevalence of liver steatosis and fibrosis
title_short Association between hypertension and the prevalence of liver steatosis and fibrosis
title_sort association between hypertension and the prevalence of liver steatosis and fibrosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116756/
https://www.ncbi.nlm.nih.gov/pubmed/37081417
http://dx.doi.org/10.1186/s12902-023-01318-1
work_keys_str_mv AT fuhuanjie associationbetweenhypertensionandtheprevalenceofliversteatosisandfibrosis
AT yuhao associationbetweenhypertensionandtheprevalenceofliversteatosisandfibrosis
AT zhaoyisheng associationbetweenhypertensionandtheprevalenceofliversteatosisandfibrosis
AT chenjinhong associationbetweenhypertensionandtheprevalenceofliversteatosisandfibrosis
AT liuzhichao associationbetweenhypertensionandtheprevalenceofliversteatosisandfibrosis